Sagimet Biosciences (SGMT) Other Working Capital Changes (2022 - 2026)

Sagimet Biosciences' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$39000.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes changed 0.0% year-over-year to -$39000.0; the TTM figure through Mar 2026 stood at -$152000.0 (down 11.76% YoY), while the FY2025 annual figure was -$152000.0, down 11.76% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$39000.0, down from -$37000.0 in the prior quarter.
• The five-year high for Other Working Capital Changes was $4.3 million in Q3 2024, with the low at -$3.3 million in Q4 2024.
• The 5-year median for Other Working Capital Changes is $121000.0 (2022), against an average of $206333.3.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes soared 38.89% in 2024, then slumped 77.27% in 2025.
• Sagimet Biosciences' Other Working Capital Changes stood at -$34000.0 in 2022, then dropped by 11.76% to -$38000.0 in 2023, then changed by 0.0% to -$38000.0 in 2024, then gained by 2.63% to -$37000.0 in 2025, then retreated by 5.41% to -$39000.0 in 2026.
• Business Quant data shows SGMT's Other Working Capital Changes at -$39000.0 in Q1 2026, -$37000.0 in Q4 2025, and -$37000.0 in Q3 2025.